Brazil: Food, Drugs, Healthcare, Life Sciences

Subscribe
Welcome to the Mondaq Food, Drugs, Healthcare, Life Sciences homepage, here you will find thought leadership articles, podcasts, videos and webinars providing insights covering topics such as Food and Drugs Law, Healthcare, Life Sciences, Biotechnology and Nanotechnology.
Article
Reprocessamento de dispositivos médicos ganha consulta pública
Brazil's health regulator ANVISA has published four public consultations that fundamentally reshape the regulatory framework for medical device reprocessing, moving from a prohibited-products list to a risk-based validation system. The proposals shift responsibility for reuse decisions to healthcare facilities while imposing new labeling requirements and authorization obligations on manufacturers, importers, and processing companies.
Brazil Healthcare
KL
KLA Advogados
Article
Atualizações regulatórias em cannabis, biossimilares e mais; confira a newsletter
Regulatory updates from ANVISA, CFM, and CFF shape strategic decisions across pharmaceutical, medical device, and supplementary health sectors. This edition covers key regulatory movements affecting strategic sectors including pharmaceutical industry, supplementary health, food products, and other regulated products, including cases involving regulatory interface with ANVISA and professional councils.
Brazil Healthcare
KL
KLA Advogados
Article
Biocon Enters Ten-Year Pertuzumab Supply Contract In Brazil
Biocon Limited has partnered with Brazilian companies Bahiafarma and Bionovis to secure an exclusive ten-year supply contract for its pertuzumab biosimilar in Brazil's public healthcare market. The partnership aims to improve access to this HER2-positive breast cancer treatment while reducing costs and developing Brazil's domestic pharmaceutical manufacturing capabilities through phased localization.
Brazil Healthcare
GP
Goodwin Procter LLP
Article
Anvisa abrirá processo para regulamentar venda de medicamentos em plataformas
Brazil's health regulatory agency Anvisa has approved the opening of an administrative process to regulate the sale and delivery of medicines through digital marketplaces, aiming to update sanitary rules to reflect the reality of online pharmaceutical retail that has evolved far beyond the outdated 2009 regulations. The decision comes after Law 15.357/2026 authorized pharmacies to contract digital platforms for logistics and delivery services, yet significant legal uncertainties remain about compliance requ
Brazil Healthcare
LA
Licks Attorneys
See more

Food and Drugs Law

Article
Reprocessamento de dispositivos médicos ganha consulta pública
Brazil's health regulator ANVISA has published four public consultations that fundamentally reshape the regulatory framework for medical device reprocessing, moving from a prohibited-products list to a risk-based validation system. The proposals shift responsibility for reuse decisions to healthcare facilities while imposing new labeling requirements and authorization obligations on manufacturers, importers, and processing companies.
Brazil Healthcare
KL
KLA Advogados
Article
Atualizações regulatórias em cannabis, biossimilares e mais; confira a newsletter
Regulatory updates from ANVISA, CFM, and CFF shape strategic decisions across pharmaceutical, medical device, and supplementary health sectors. This edition covers key regulatory movements affecting strategic sectors including pharmaceutical industry, supplementary health, food products, and other regulated products, including cases involving regulatory interface with ANVISA and professional councils.
Brazil Healthcare
KL
KLA Advogados
Article
Anvisa abrirá processo para regulamentar venda de medicamentos em plataformas
Brazil's health regulatory agency Anvisa has approved the opening of an administrative process to regulate the sale and delivery of medicines through digital marketplaces, aiming to update sanitary rules to reflect the reality of online pharmaceutical retail that has evolved far beyond the outdated 2009 regulations. The decision comes after Law 15.357/2026 authorized pharmacies to contract digital platforms for logistics and delivery services, yet significant legal uncertainties remain about compliance requ
Brazil Healthcare
LA
Licks Attorneys
See more

Life Sciences, Biotechnology & Nanotechnology

Article
Atualizações regulatórias em cannabis, biossimilares e mais; confira a newsletter
Regulatory updates from ANVISA, CFM, and CFF shape strategic decisions across pharmaceutical, medical device, and supplementary health sectors. This edition covers key regulatory movements affecting strategic sectors including pharmaceutical industry, supplementary health, food products, and other regulated products, including cases involving regulatory interface with ANVISA and professional councils.
Brazil Healthcare
KL
KLA Advogados
Article
Biocon Enters Ten-Year Pertuzumab Supply Contract In Brazil
Biocon Limited has partnered with Brazilian companies Bahiafarma and Bionovis to secure an exclusive ten-year supply contract for its pertuzumab biosimilar in Brazil's public healthcare market. The partnership aims to improve access to this HER2-positive breast cancer treatment while reducing costs and developing Brazil's domestic pharmaceutical manufacturing capabilities through phased localization.
Brazil Healthcare
GP
Goodwin Procter LLP
See more

Healthcare

Article
Reprocessamento de dispositivos médicos ganha consulta pública
Brazil's health regulator ANVISA has published four public consultations that fundamentally reshape the regulatory framework for medical device reprocessing, moving from a prohibited-products list to a risk-based validation system. The proposals shift responsibility for reuse decisions to healthcare facilities while imposing new labeling requirements and authorization obligations on manufacturers, importers, and processing companies.
Brazil Healthcare
KL
KLA Advogados
Article
Ministry Of Health Indicates Next Steps For ENSCEIS Regulation
Brazil's Ministry of Health is advancing the regulatory framework for the National Health Strategy for the Health Economic-Industrial Complex (ENSCEIS), established by Statute #15,471 of July 20, 2026. The framework aims to strengthen domestic production and innovation capacity in the health sector while reducing dependence on foreign technology and expanding access to strategic health technologies for Brazil's public healthcare system.
Brazil Government
LA
Licks Attorneys
Article
Atualizações regulatórias em cannabis, biossimilares e mais; confira a newsletter
Regulatory updates from ANVISA, CFM, and CFF shape strategic decisions across pharmaceutical, medical device, and supplementary health sectors. This edition covers key regulatory movements affecting strategic sectors including pharmaceutical industry, supplementary health, food products, and other regulated products, including cases involving regulatory interface with ANVISA and professional councils.
Brazil Healthcare
KL
KLA Advogados
See more